Astrotech vs Bionexus Gene Lab
Bionexus Gene Lab is the larger business, with $7.4m of revenue in fiscal 2025 against $913,000 for Astrotech (8.1 times as much). Astrotech grew faster (-8.7% against -21.9%). Bionexus Gene Lab kept more of each dollar of sales as profit: a net margin of -40.2% against -1580.2%.
| Latest fiscal year | AstrotechASTC, 2026 | Bionexus Gene LabBGLC, 2025 |
|---|---|---|
| Revenue | $913,000 | $7.4m |
| Revenue growth | -8.7% | -21.9% |
| Net income | −$14.4m | −$3.0m |
| Operating margin | -1548.5% | — |
| Net margin | -1580.2% | -40.2% |
| Return on equity | -75.4% | -35.2% |
| Free cash flow | −$14.3m | −$1.9m |
| Cash | $8.4m | $2.4m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $9.7m | $2.3m |
| Price vs our value range | — | — |
| Moat score | 9 (Weak) | 23 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |